| Prev Close: | 84.23 |
|---|---|
| Open: | 84.44 |
| Bid: | 85.00 x 100 |
| Ask: | 85.16 x 2000 |
| 1y Target Est: | 86.50 |
| Beta: | 0.47 |
| Next Earnings Date: | 15-Jul-13 |
| Day's Range: | 84.17 - 85.21 |
|---|---|
| 52wk Range: | 61.71 - 85.89 |
| Volume: | 8,670,010 |
| Avg Vol (3m): | 9,694,550 |
| Market Cap: | 238.05B |
| P/E (ttm): | 23.13 |
| EPS (ttm): | 3.68 |
| Div & Yield: | 2.64 (3.10%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Final Glance: Pharmaceuticals companiesAP(Thu 6:05PM EDT)
- Final Glance: Medical Devices companiesAP(Thu 6:05PM EDT)
- Decades-old question: Is antibacterial soap safe?AP(Thu 5:58PM EDT)
- Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)PR Newswire(Thu 5:00PM EDT)
- Johnson & Johnson (JNJ): Today's Featured Health Care Winnerat TheStreet(Thu 5:00PM EDT)
- Decades-old question: Is anti-bacterial soap safe?AP(Thu 1:46PM EDT)
- Wider-Than-Expected Loss at PharmacyclicsZacks(Thu 1:30PM EDT)
- Midday Glance: Pharmaceuticals companiesAP(Thu 1:26PM EDT)
- Midday Glance: Medical Devices companiesAP(Thu 1:26PM EDT)
- The 10 most overbought names in the S&P 500at MarketWatch(Thu 12:55PM EDT)
- Blue Chip Stocks Fetch Ridiculous Valuations, But Don't Sell Just Because It's Mayat Forbes(Thu 12:37PM EDT)
- Decade-old question: Is anti-bacterial soap safe?AP(Thu 12:06PM EDT)
- Decade-old question: Is antibacterial soap safe?AP(Thu 11:57AM EDT)
- Has Krugman Really Won?at Seeking Alpha(Thu 10:45AM EDT)
- Why You Should Buy This Blue Chip Stockat Motley Fool(Thu 10:10AM EDT)
Press Releases
- Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)PR Newswire(Thu 5:00PM EDT)
- Johnson & Johnson Announces Dividend Increase of 8.2%PR Newswire(Thu, Apr 25)
- Johnson & Johnson to Host Pharmaceuticals Business ReviewPR Newswire(Tue, Apr 23)
Reports
- JNJ: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 2)
- Thomson Reuters Stock Report - JOHNSON & JOHNSON (JNJ-N)Thomson Reuters Stock Report(May 2)
- JNJ - Johnson & Johnson - Downgraded to a Sell - Research Report by ASRAlpha Street Research(Apr 29)